C. L. Davis

C. A. Chavez2
V. E. Blinov2
M. R. Monge2
2C. A. Chavez
2V. E. Blinov
2M. R. Monge
Learn More
Thirty-four patients with previously treated, advanced, low grade NHL were treated with Fludarabine, a deamination-resistant analogue of adenosine arabinoside, at a dose of 25 mg m-2 intravenously, daily for 5 days (median number of cycles = 3, range 1-10). Complete remission (CR) was achieved in six and partial remission (PR) in a further seven. Overall,(More)
  • 1